Understanding What Peptide Delivery Groups Can Learn from Pre-clinical & Clinical Experience with ADCs
Time: 2:15 pm
day: Conference Day 2
Details:
- A brief review of ADC toxicity mechanisms
- Key differences between peptides and antibodies with regards to toxicity profiles
- Clinical experience with Bicycle Toxin Conjugates
